Marc Forth serves as Executive at AEON Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Marc Forth has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 31, 2024 involved receiving (via award) 470,692 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 31, 2024 | AEON | $0 | Award | 470,692 | $N/A | Discretionary |
Marc Forth currently holds 750,547 shares of AEON Biopharma, Inc. (AEON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Forth has been a net neutral trader of AEON stock. They have purchased $0 and sold $0 worth of shares.
Marc Forth's most recent insider trade was on Aug 31, 2024, when they sold 470,692 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted